| Market Cap | 401.95M | P/E | - | EPS this Y | -18.50% | Ern Qtrly Grth | - |
| Income | -126.68M | Forward P/E | -3.11 | EPS next Y | 2.50% | 50D Avg Chg | 9.00% |
| Sales | 32.04M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 38.00% |
| Dividend | N/A | Price/Book | 3.01 | EPS next 5Y | - | 52W High Chg | -2.00% |
| Recommedations | 2.20 | Quick Ratio | 8.69 | Shares Outstanding | 48.02M | 52W Low Chg | 208.00% |
| Insider Own | 3.77% | ROA | -38.53% | Shares Float | 43.66M | Beta | 0.52 |
| Inst Own | 77.05% | ROE | -108.68% | Shares Shorted/Prior | 1.08M/2.17M | Price | 8.37 |
| Gross Margin | -220.53% | Profit Margin | - | Avg. Volume | 2,542,039 | Target Price | 13.00 |
| Oper. Margin | -287.97% | Earnings Date | Aug 2 | Volume | Change | 0.00% |
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
| JonesTrading | Hold | Jan 20, 23 |
| Truist Securities | Buy | Sep 13, 22 |
| JonesTrading | Buy | Aug 25, 22 |
| Mizuho | Buy | Oct 5, 21 |
| Truist Securities | Buy | Feb 2, 21 |
| Berenberg | Buy | Dec 16, 20 |
| H.C. Wainwright | Buy | Oct 3, 19 |
| SunTrust Robinson Humphrey | Buy | Sep 30, 19 |
| Mizuho | Buy | Sep 30, 19 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Stuart Nancy | Chief Operating Offi.. Chief Operating Officer | Feb 15 | Sell | 8.33 | 6,048 | 50,380 | 262,596 | 02/16/23 |
| Munsie Jeffrey A | Chief Legal Officer Chief Legal Officer | Feb 15 | Sell | 8.34 | 3,762 | 31,375 | 88,049 | 02/16/23 |
| Cassella James V | Chief Development Of.. Chief Development Officer | Feb 15 | Sell | 8.34 | 3,762 | 31,375 | 173,061 | 02/16/23 |
| Becker Marc A. | Chief Financial Offi.. Chief Financial Officer | Feb 15 | Sell | 8.33 | 3,762 | 31,337 | 123,863 | 02/16/23 |
| Stuart Nancy | Chief Operating Offi.. Chief Operating Officer | Jan 30 | Sell | 8.35 | 13,200 | 110,220 | 268,644 | 01/31/23 |
| Munsie Jeffrey A | Chief Legal Officer Chief Legal Officer | Jan 30 | Sell | 8.35 | 8,493 | 70,917 | 91,811 | 01/31/23 |
| Cassella James V | Chief Development Of.. Chief Development Officer | Jan 30 | Sell | 8.35 | 10,106 | 84,385 | 176,823 | 01/31/23 |
| Becker Marc A. | Chief Financial Offi.. Chief Financial Officer | Jan 30 | Sell | 8.35 | 8,493 | 70,917 | 127,625 | 01/31/23 |
| van Heek Christi | Director Director | Jun 06 | Buy | 4.75 | 10,526 | 49,998 | 25,651 | 06/06/22 |
| Auchincloss Thomas G | Director Director | Jun 06 | Buy | 4.75 | 6,000 | 28,500 | 17,625 | 06/06/22 |
| ALDRICH RICHARD | Director Director | Jun 06 | Buy | 4.75 | 210,526 | 999,998 | 210,526 | 06/06/22 |
| Tung Roger D | Chief Executive Offi.. Chief Executive Officer | Feb 15 | Sell | 3.09 | 13,480 | 41,653 | 980,258 | 02/16/22 |
| Stuart Nancy | Chief Operating Offi.. Chief Operating Officer | Feb 14 | Sell | 3.08 | 6,049 | 18,631 | 284,737 | 02/16/22 |
| Munsie Jeffrey A | Chief Legal Officer Chief Legal Officer | Feb 14 | Sell | 3.09 | 3,762 | 11,625 | 103,197 | 02/16/22 |
| Cassella James V | Chief Development Of.. Chief Development Officer | Feb 14 | Sell | 3.09 | 3,762 | 11,625 | 189,822 | 02/16/22 |
| Becker Marc A. | Chief Financial Offi.. Chief Financial Officer | Feb 14 | Sell | 3.08 | 3,762 | 11,587 | 139,011 | 02/16/22 |
| Tung Roger D | Chief Executive Offi.. Chief Executive Officer | Dec 13 | Option | 3.5 | 6,700 | 23,450 | 815,278 | 12/15/21 |
| Tung Roger D | Chief Executive Offi.. Chief Executive Officer | Dec 13 | Sell | 3.62 | 6,700 | 24,254 | 808,578 | 12/15/21 |